Search for a clinical trial
Other search option(s)
HEP 001: A prospective, open label, multicenter, partially randomised, safety study of one cycle of Promethera HepaStem in Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) paediatric patients - IT
- Type of clinical trial : Cell therapy clinical trial
- Recruiting project : No
- Status : Terminated trial
- Funding body(ies) :
- Geographic coverage : Global
- Sponsor : Promethera biosciences
- Phase : I - II
Download document
Principal investigator of clinical trial
- INFORMATION NOT PROVIDED
- Institution: Information not provided - IT
- 40121 ADDRESS: NOT PROVIDED - IT
- ITALY
- More information
- Phone : -
- Fax : -
Sponsor of clinical trial
- PROMETHERA BIOSCIENCES
- Promethera Biosciences
- Watson & Crick Hill Rue Granbonpré, 11
- B-1435 MONT-SAINT-GUIBERT
- BELGIUM
- More information
- Phone : 32 (0)10 39 43 00
- Fax : -
- Website
- Contact secretary :
email
Last update: January 2014
Part of a multinational clinical trial
BELGIUM
BRUSSELS
Cliniques universitaires Saint-Luc - UCLouvain
Additional information
Further information on this research
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.